Stereotactic body radiation therapy for hepatocellular carcinoma: a comprehensive review
Open Access
- 29 January 2026
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 16, 1747449
Abstract
Hepatocellular carcinoma (HCC) presents significant challenges in modern surgical and radiation oncology, primarily due to biological heterogeneity and the complexities of underlying liver cirrhosis. This review evaluates stereotactic body radiation therapy (SBRT) as a mature, curative-intent modality within the multidisciplinary management of primary hepatic malignancies. Drawing parallels with high-dose-per-fraction successes in early-stage non-small cell lung cancer, pancreatic adenocarcinoma, and spinal metastases, we analyze the physical evolution, radiobiological principles, and functional dosimetric constraints specific to the hepatic microenvironment. Specifically, we examine advanced motion management, distinguishing pre-treatment setup from real-time intrafractional monitoring via kilovoltage projection streaming images (kV-PSI) and MR-guidance. We evaluate the prognostic value of metabolic imaging parameters, specifically SUL peak and radiomic signatures, alongside the therapeutic synergy between SBRT and systemic agents, including tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs). Additionally, the review explores the emerging role of artificial intelligence (AI) in automating planning and executing real-time online adaptive radiotherapy (ART). Finally, by synthesizing pathological evidence of complete necrosis in explanted specimens following conversion therapy, this work provides a roadmap for optimizing SBRT across the clinical spectrum of HCC.Keywords
This publication has 65 references indexed in Scilit:
- The Kidney Precision Medicine Project and Single-Cell Biology of the Injured Proximal TubuleThe American Journal of Pathology, 2024
- Spatial whole transcriptome profiling of primary tumor from patients with metastatic prostate cancerInternational Journal of Cancer, 2023
- Downregulated hsa_circ_0077837 and hsa_circ_0004826, facilitate bladder cancer progression and predict poor prognosis for bladder cancer patientsCancer Medicine, 2020
- An important intestinal transporter that regulates the enterohepatic circulation of bile acids and cholesterol homeostasis: The apical sodium-dependent bile acid transporter (SLC10A2/ASBT)Clinics and Research in Hepatology and Gastroenterology, 2017
- Comment on stereotactic body radiation therapy for small primary or recurrent hepatocellular carcinoma-Authors’ replyJournal of Surgical Oncology, 2016
- Awakening the immune system with radiation: Optimal dose and fractionationCancer Letters, 2015
- Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based studyJournal of Cancer Research and Clinical Oncology, 2015
- Diagnostic accuracy of 11C-choline PET/CT in comparison with CT and/or MRI in patients with hepatocellular carcinomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2015
- Identification of circulating MicroRNAs as novel potential biomarkers for hepatocellular carcinoma detection: a systematic review and meta-analysisClinical and Translational Oncology, 2015
- The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT)Journal of Cancer Research and Clinical Oncology, 2015